Clinical
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Action Update, February 2026: Complete Response Letter, Expanded Indication, and Acceptance
2
Study Identifies NRN1 as Therapeutic Target Candidate for Alzheimer Disease
3
GB221 Gene Therapy Enters First-in-Human CHARISMA Trial for Spinal Muscular Atrophy Type 1
4
Fenebrutinib Achieves Primary End Point in Phase 3 Head-to-Head Trial vs Teriflunomide in Relapsing MS
5